ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.91283
0.04%
Brent Oil
82.795
-0.08%
Bitcoin
62,649.54
0.51%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. 180 Life Sciences Corporation (ATNF)

  7. 180 Life Sciences Corporation (ATNF) Noticias

ATNF 180 Life Sciences Corporation

2.01
0.14 (7.49%)
07 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
180 Life Sciences Corporation ATNF NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.14 7.49% 2.01 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.90 1.90 2.3583 2.01 1.87
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/3/202407:30GLOBE180 Life Sciences Regains Full Compliance with Nasdaq ..
11/3/202406:03EDGAR2Form 8-K - Current report
08/3/202415:49EDGAR2Form 8-K - Current report
29/2/202407:00EDGAR2Form 8-K - Current report
28/2/202405:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202405:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202405:37EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202405:30EDGAR2Form 8-K - Current report
26/2/202406:00EDGAR2Form 8-K - Current report
26/2/202406:00GLOBE180 Life Sciences Corp. Announces 1-For 19 Reverse Stock..
20/2/202407:01EDGAR2Form 8-K - Current report
16/2/202416:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202416:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202416:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/2/202415:15EDGAR2Form 8-K - Current report
12/2/202415:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202416:29EDGAR2Form S-1 - General form for registration of securities under..
29/1/202407:00EDGAR2Form 8-K - Current report
17/1/202407:30EDGAR2Form 8-K - Current report
16/1/202407:30EDGAR2Form 8-K - Current report
28/12/202317:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202315:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/12/202315:15EDGAR2Form DEF 14A - Other definitive proxy statements
21/12/202316:00EDGAR2Form 8-K - Current report
20/12/202307:00EDGAR2Form 8-K - Current report
18/12/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202307:30EDGAR2Form 8-K - Current report
14/12/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
04/12/202308:00EDGAR2Form 8-K - Current report
04/12/202308:00GLOBE180 Life Sciences Engages Financial Advisor to Explore..
30/11/202316:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202316:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202307:10EDGAR2Form 8-K - Current report
28/11/202308:00EDGAR2Form 8-K - Current report
28/11/202308:00GLOBE180 Life Sciences Announces Review of Strategic Alternatives
16/11/202315:30EDGAR2Form 8-K - Current report
09/11/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/10/202315:33EDGAR2Form 8-K - Current report
13/10/202316:00EDGAR2Form 8-K - Current report
28/9/202315:18EDGAR2Form 8-K - Current report
22/9/202308:00EDGAR2Form 8-K - Current report
08/9/202315:30EDGAR2Form 8-K - Current report
08/9/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202307:30EDGAR2Form 8-K - Current report
06/9/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202317:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/8/202316:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202316:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Su Consulta Reciente

NASDAQ
ATNF
180 Life Sciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados